EP Patent

EP2455076A1 — Compositions comprising desvenlafaxine for use in treating sleep-related breathing disorders

Assigned to Sumitomo Pharma America Inc · Expires 2012-05-23 · 14y expired

What this patent protects

Provided herein are methods of treating a sleep-related breathing disorder, such as obstructive sleep apnea, comprising the administration of O-desmethylvenlafaxine or duloxetine.

USPTO Abstract

Provided herein are methods of treating a sleep-related breathing disorder, such as obstructive sleep apnea, comprising the administration of O-desmethylvenlafaxine or duloxetine.

Drugs covered by this patent

Patent Metadata

Patent number
EP2455076A1
Jurisdiction
EP
Classification
—
Expires
2012-05-23
Drug substance claim
No
Drug product claim
No
Assignee
Sumitomo Pharma America Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.